Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

OSTEOBOOST-BMA

K-Number: K062260 · 2006-10-26

Decision Date2006-10-26
Product CodeFMF
Advisory CommitteeHO
DecisionSubstantially Equivalent

Device Summary

OSTEOBOOST-BMA is the device name listed in this FDA 510(k) record. The listed applicant is Orthos Limited. It received FDA 510(k) clearance on 2006-10-26 under 510(k) number K062260. The device is classified under product code FMF. It was reviewed by the HO advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the OSTEOBOOST-BMA?

OSTEOBOOST-BMA is a medical device that received FDA 510(k) clearance on 2006-10-26. The listed applicant is Orthos Limited. The 510(k) number is K062260.

When did OSTEOBOOST-BMA receive FDA 510(k) clearance?

OSTEOBOOST-BMA received FDA 510(k) clearance on 2006-10-26, under 510(k) number K062260.

Who is the listed applicant for OSTEOBOOST-BMA?

The FDA 510(k) record lists Orthos Limited as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for OSTEOBOOST-BMA?

The FDA product code for OSTEOBOOST-BMA is FMF.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: FMF)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑